Next generation sequencing in the oncology clinic: the future for the treating physician - J. Rodón

7 April 2017

Genomics in Oncology lecture series invites Jordi Rodón, MD, PhD, Clinical Oncologist and Director of the Research Unit for Molecular Therapy of Cancer at Vall d´Hebron in Barcelona. Dr. Rodón discusses the use of next-generation sequencing to empower the future of precision medicine in oncology drug development. Learn more about genomics in oncology, visit our website: http://www.illumina.com/areas-of-interest/cancer/research.html A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015. Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc View customer spotlight videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79 View Illumina webinars https://www.youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ View Illumina product videos https://www.youtube.com/playlist?list=PLKRu7cmBQlaj6YuZmkfxZcT9twqDgP2Xd View Illumina support videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM

Share this article on